Morgan Stanley Downgrades PagerDuty as Insiders Sell Into Strength
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
PD enters the back half of the week in a difficult spot: a fresh Morgan Stanley downgrade landed Tuesday, insiders have been selling consistently into the recent price recovery, and the stock has given back nearly 15% on the week to close at $9.39.
The analyst move is the sharpest signal. Morgan Stanley's Sanjit Singh downgraded PD to Underweight on July 21 — the first time the firm has moved to a negative rating — and cut the price target to $9.00 from $10.00, leaving it fractionally below Tuesday's close. That's a meaningful shift in tone from a bellwether firm, and it arrives just weeks after Truist raised its target to $11.00 on July 9, maintaining a Buy. The Street is now split: bulls at Truist and Canaccord point to a new CRO hire, AI-native customer momentum, and a $499 million ARR base as the foundation for a fiscal 2027 acceleration. Bears — now with Morgan Stanley as their most prominent voice — flag a deteriorating net revenue retention rate (down to 98%, the sixth consecutive quarterly decline) and TTM billings growth of just 4% year-over-year, well short of expectations. The consensus target has compressed to $9.43, barely above current levels, suggesting the Street as a whole sees little near-term upside.
The insider picture reinforces that cautious read. Executive Chairman Jennifer Tejada sold a combined 399,000 shares on July 16 and 17 — worth roughly $4.2 million — at prices between $10.41 and $10.70, well above where the stock closed Tuesday. The CFO and Chief Accounting Officer both sold smaller tranches on July 2 as well. Over the past 90 days, insiders have net-sold nearly $8.4 million worth of stock, with no offsetting purchases visible in the record. That's not a panic signal — many of these are likely programmatic dispositions — but the timing, selling into the stock's strongest month in a year, is worth noting.
Positioning in the lending market tells a different story — one that's notably calm given the week's drama. Borrow availability is extremely loose, running above 1,200%, meaning roughly twelve shares are available to lend for every one currently borrowed. Cost to borrow is negligible at under 0.5%, roughly flat on the week. Short interest, at 7.6% of the free float, has actually drifted lower from a month ago when it was running above 8.5%. In other words, the bears expressing a view through short positions have not piled in aggressively — and the lending market offers no squeeze dynamic to exploit. Options traders meanwhile have turned more call-leaning than usual. The put/call ratio at 0.41 is about 1.3 standard deviations below its 20-day average, closer to its 52-week low of 0.09 than its high of 0.85. That's a market leaning bullish through options even as the stock falls — possibly hedgers rolling or speculative buyers picking at the dip.
Peers provide useful context on the session's weakness. TEAM fell 6% on the day and WDAY dropped 4.1%, so some of PD's Tuesday move reflects sector-wide selling rather than stock-specific pressure. ASAN and CRM each fell 2–3%. Over the full week, PD's 14.6% decline stands out even against that soft backdrop — ZETA is the only peer down more on the week at nearly 6%.
The next earnings print is scheduled for September 3. Between now and then, the key friction point is whether the Morgan Stanley downgrade changes the buy-side conversation around net revenue retention, or whether the bulls' argument — that AI-native customer additions and the new CRO can inflect growth by fiscal 2027 — holds enough weight to stabilise the valuation near the $9 handle.
Stocks in this article
See the live data behind this article on ORTEX.
Open PD on ORTEX →How this article was generated
- Generated
- 22 Jul 2026, 20:15
- Data as of
- 22 Jul 2026, 20:15
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notes
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.